Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cleary

Showing results (21-30 of 334) with videos related to

Pageof 34
Sort By:
Blood|April 15, 1994
Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cellsL Naumovski, M L Cleary
Bioinformatics (Oxford, England)|December 26, 2001
Progenetix.net: an online repository for molecular cytogenetic aberration dataM Baudis, M L Cleary
Journal of Continuing Education in Nursing|August 2, 2012
Developing and using multiple-choice tests in clinical settingsMichelle L Cleary, Jan Horsfall
Cancer Surveys|January 1, 1985
DNA rearrangements in non-Hodgkin's lymphomasM L Cleary, J Sklar
Lancet (London, England)|September 1, 1984
Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomasM L Cleary, J Sklar
Cancer Cell|July 5, 2008
Menin critically links MLL proteins with LEDGF on cancer-associated target genesAkihiko Yokoyama, Michael L Cleary
Journal of Continuing Education in Nursing|September 29, 2006
STUDY TOURS: getting the most out of study toursMichelle L Cleary, Garry Walter
Blood|October 24, 2002
Common mechanism for oncogenic activation of MLL by forkhead family proteinsChi Wai So, Michael L Cleary
The Journal of Biological Chemistry|March 25, 1990
Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitroZ Chen-Levy, M L Cleary
Molecular and Cellular Biology|August 23, 2002
MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein functionChi Wai So, Michael L Cleary
Pageof 34

Showing results (21-30 of 334) with videos related to

Sort By:
Pageof 34
Blood|April 15, 1994
Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cellsL Naumovski, M L Cleary
Bioinformatics (Oxford, England)|December 26, 2001
Progenetix.net: an online repository for molecular cytogenetic aberration dataM Baudis, M L Cleary
Journal of Continuing Education in Nursing|August 2, 2012
Developing and using multiple-choice tests in clinical settingsMichelle L Cleary, Jan Horsfall
Cancer Surveys|January 1, 1985
DNA rearrangements in non-Hodgkin's lymphomasM L Cleary, J Sklar
Lancet (London, England)|September 1, 1984
Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomasM L Cleary, J Sklar
Cancer Cell|July 5, 2008
Menin critically links MLL proteins with LEDGF on cancer-associated target genesAkihiko Yokoyama, Michael L Cleary
Journal of Continuing Education in Nursing|September 29, 2006
STUDY TOURS: getting the most out of study toursMichelle L Cleary, Garry Walter
Blood|October 24, 2002
Common mechanism for oncogenic activation of MLL by forkhead family proteinsChi Wai So, Michael L Cleary
The Journal of Biological Chemistry|March 25, 1990
Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitroZ Chen-Levy, M L Cleary
Molecular and Cellular Biology|August 23, 2002
MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein functionChi Wai So, Michael L Cleary
Pageof 34